Talisman Metals PLC

7.75pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:TLMHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 10Y CAGR (13.16%)
Div yield —
ROE (112.16%)
Pharmaceutical Preparations
Beta (5Y) 1.16
PE TTM 0.689
TSR TTM —
Mkt cap £5.529M
ROIC (65.32%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
8.31p
7.26%
335.55%
Hold 11|12|8|12|9
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.18
0.19
0.20
0.21
9.07%
18.91%
15.33%
21.17%
Revenue€M
0.691
0.688
0.701
0.728
4.96%
0.81%
4.58%
6.85%
Peers (US$7.440M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.951
(0.572)
(0.302)
EBIT/Intx
0.677
1.250
1.157
Own earn%
388.79
140.72
137.09
Sh yield%
23.62
21.53
22.31
Owners
Insiders/Inst%
14.77
39.84
Short interest%
5.06
SBC / revenue%
3.98
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
0–4
$1 testx
—
Incr. ROIC%
1